M, T., M, P., I, C., C, B., A, D. M., V, M., . . . G, P. (2026). Interleukin-18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin-1 Inhibitors. Arthritis & rheumatology (Hoboken, N.J.), 78(6), 1327. https://doi.org/10.1002/art.70024
Chicago Style (17th ed.) CitationM, Trevisan, Pardeo M, Caiello I, Bracaglia C, De Matteis A, Matteo V, Loricchio E, De Benedetti F, and Prencipe G. "Interleukin-18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin-1 Inhibitors." Arthritis & Rheumatology (Hoboken, N.J.) 78, no. 6 (2026): 1327. https://doi.org/10.1002/art.70024.
MLA (9th ed.) CitationM, Trevisan, et al. "Interleukin-18 Levels Are Associated With Disease Course in Patients With Still Disease Treated With Interleukin-1 Inhibitors." Arthritis & Rheumatology (Hoboken, N.J.), vol. 78, no. 6, 2026, p. 1327, https://doi.org/10.1002/art.70024.